Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Inflammatory Blood Biomarkers for Clinical Management, Prognosis and Evaluation of Interventions

NCT04363008 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT04363008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04363008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Inflammatory Blood Biomarkers for Clinical Management, Prognosis and Evaluation of Interventions
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Unknown status
Start date
March 30, 2020
Completion date
September 30, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19